IrriMax Corporation: IrriSept(R) O.R. to Be Introduced at the 2011 AORN Congress

ATLANTA--(BUSINESS WIRE)--Association of periOperative Registered Nurses (AORN) members attending the 58th Annual Congress will be among the first in the nation to be introduced to IrriSept® O.R. (www.irrisept.com), the first and only FDA-cleared wound debridement and cleansing system containing chlorhexidine gluconate (CHG). The 0.05 percent CHG concentration in IrriSept has been shown effective in laboratory testing against a variety of bacteria and fungi, including Staph and methicillin-resistant Staphylococcus aureus (MRSA).1,2 The solution has passed FDA-required tests for cytotoxicity, skin irritation and immune (allergic) response.3